Venture Capital: ViaNautis Bio Lands $25M Series A For Nanomedicines

November 13, 2023 | News, Venture Capital

The ViaNautis fundraise is pivotal, marking a significant step in its journey towards advancing gene therapy and creating value for shareholders.

ViaNautis Bio has secured $25 million in Series A financing to propel the development of its groundbreaking genetic nanomedicines. The company’s proprietary drug delivery platform, polyNaut®, facilitates the transfer of genetic therapeutic payloads across challenging biological barriers, aiming to create new treatments for diseases with unmet clinical needs. Led by 4BIO Capital, BGF, and UCB Ventures, alongside the Cystic Fibrosis Foundation and Eli Lilly and Company, this funding round will accelerate product development, expand teams, and establish cutting-edge laboratory facilities.

PolyNaut® is noted for its use of advanced polymer materials and in silico screening to precisely target genetic molecules like pDNA, mRNA, siRNA, and ASOs. This innovation tackles the hurdle of transporting genetic materials across biological barriers, holding promise for conditions with urgent unmet needs, including Cystic Fibrosis and CNS diseases. ViaNautis’s pipeline includes VNS002, focusing on formulating candidates for targeted delivery to the lungs. (Yahoo Finance)

Established in 2018, ViaNautis emerged from UCL, founded by Dr. Francesca Crawford, Dr. Denis Cecchin, and Professor Giuseppe Battaglia, the inventor of polyNaut®. Francesca Crawford, ViaNautis’s CEO, highlights the potential to address CNS and lung diseases. The fundraise is pivotal, marking a significant step in ViaNautis’s journey towards advancing gene therapy and creating value for shareholders.

Related Story:  Rapport Therapeutics Raises $150 Million For Precision Neuromedicines

Photo by THAVIS 3D on Unsplash

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Latest Alternative Investment News
Artificial Intelligence: AMD Takes On Rivals In The AI Chip Sweepstakes
December 7, 2023     Artificial Intelligence, News

Chipmaker AMD (NASDAQ: AMD) has unveiled a range of innovative AI solutions spanning from data centers to personal computers. The AMD Instinct MI300 Series features data center AI accelerators, while…
Digital Assets: Robinhood Debuts Crypto Trading On Its App In The EU
December 7, 2023     Digital Assets, FinTech, News

Robinhood (NASDAQ: HOOD) has launched its Crypto app in the European Union (EU), allowing eligible customers to engage in crypto trading with the added incentive of earning Bitcoin rewards. Customers…
FinTech: Samsung Electronics Ties With Mastercard’s Wallet Express
December 7, 2023     FinTech, News

Samsung Electronics (KRX: 005930) and Mastercard (NYSE: MA) have partnered to launch the Wallet Express program, offering banks and card issuers a cost-effective way to expand digital wallet offerings. Through…
Venture Capital: Revaia, Europe’s Biggest Female-Led VC Firm, Racks Up $160M For Second Fund
December 7, 2023     ESG and Sustainability, News, Venture Capital

Revaia, Europe’s largest female-founded venture capital firm, has successfully raised €150 million ($160 million) for its second fund, Revaia Growth II. The funding was secured from sovereign wealth funds, family…